Intrinsiqs

Is Latigo Biotherapeutics Inc. overvalued?

Latigo Biotherapeutics Inc. (LTGO) — key valuation metrics and fundamentals.

No verdict
Price
$19.63
Fair value
Current P/E
Normal P/E
Market cap
$1.18B
Dividend yield
Return on equity
Sector
Healthcare

See the full interactive analysis →

Fair value compares LTGO's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 13 Aug 2026.